Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Intradialytic Hematocrit and Oxygen Saturation Monitoring During Continuous Kidney Replacement Therapy

NCT07428395 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT07428395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07428395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Intradialytic Hematocrit and Oxygen Saturation Monitoring During Continuous Kidney Replacement Therapy
Lead sponsor
University of Pennsylvania
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 17, 2026
Completion date
March 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, dialysis, end stage chronic renal failure